Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about precision drugs unmasking cancers to the immune system, become a cheering team volunteer or take our drug access survey.

Cancer – and avoiding the blame game

Leading childhood leukaemia researcher Professor Sir Mel Greaves, discusses the difficulties of avoiding blame and responsibility when it comes to cancer.
Read more
3D printed tungsten could improve gamma camera images

A honeycomb of tungsten built using 3D printing could help take better quality images of processes inside the body, a new study shows.
Read more
Tell us about your experiences with cancer drug access

Have you been treated for cancer in the UK? We need your help! We’re interested in your views about whether a good job is being done getting the latest cancer drugs to patients.
Take our survey
Prostate Cancer Awareness Month 2019: Six of our latest advances

We take a look back at some of the progress made in prostate cancer research at the ICR over the last 12 months.
Read more
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy.
Read more

1/5

Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more